Swiss National Bank acquired a new stake in shares of Personalis, Inc. (NASDAQ:PSNL – Free Report) during the 1st quarter, according to its most recent 13F filing with the SEC. The firm acquired 105,400 shares of the company’s stock, valued at approximately $671,000. Swiss National Bank owned 0.10% of Personalis at the end of the […]

Swiss National Bank acquired a new position in CytomX Therapeutics, Inc. (NASDAQ:CTMX – Free Report) during the first quarter, Holdings Channel reports. The firm acquired 319,600 shares of the biotechnology company’s stock, valued at approximately $1,502,000. Several other large investors also recently added to or reduced their stakes in the business. Orbimed Advisors LLC purchased […]

Swiss National Bank bought a new stake in shares of Annexon, Inc. (NASDAQ:ANNX – Free Report) in the 1st quarter, according to the company in its most recent filing with the SEC. The fund bought 236,000 shares of the company’s stock, valued at approximately $1,307,000. A number of other large investors also recently made changes […]